Meta-Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority

Witjes, H; Khatri, A; Diderichsen, PM; Mandema, J; Othman, AA

Othman, AA (corresponding author), AbbVie Inc, Clin Pharmacol & Pharmacometr, N Chicago, IL 60064 USA.

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020; 107 (2): 435

Abstract

Risankizumab, an anti-interleukin-23 monoclonal antibody, achieved significantly (P < 0.001) greater Psoriasis Area and Severity Index (PASI) and s......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索